Biotechnology Assets, S.A. (BME:BST)
0.3550
-0.0010 (-0.28%)
Oct 28, 2025, 12:54 PM CET
Biotechnology Assets Employees
Biotechnology Assets had 34 employees as of December 31, 2024. The number of employees decreased by 3 or -8.11% compared to the previous year.
Employees
34
Change (1Y)
-3
Growth (1Y)
-8.11%
Revenue / Employee
€87,210
Profits / Employee
€85,803
Market Cap
24.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34 | -3 | -8.11% |
| Dec 31, 2023 | 37 | 3 | 8.82% |
| Dec 31, 2022 | 34 | 1 | 3.03% |
| Dec 31, 2021 | 33 | 4 | 13.79% |
| Dec 31, 2020 | 29 | -315 | -91.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 23,833 |
| Laboratorios Farmaceuticos Rovi | 2,197 |
| Atrys Health | 2,045 |
| Almirall | 2,026 |
| Faes Farma | 1,775 |
| Clínica Baviera | 1,759 |
| Laboratorio Reig Jofre | 1,437 |
| Prim, S.A. | 958 |